Neoplasm observable
|
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy (observable entity)
Presence of regression of primary malignant neoplasm after neoadjuvant antineoplastic therapy
Id
1255588004
Status
Defined
Inheres in
maligne neoplasma
Property
Presence
Scale type
Ordinal value
Characterizes
maligne proliferatie van primair neoplasma
Characterizes
regressie van neoplasma
Precondition
neoadjuvante antineoplastische therapie
Time aspect
Single point in time
|
Presence of regression of Ewing's sarcoma after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant gastrointestinal stromal sarcoma after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant mesothelioma after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of anus after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of bone after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of breast after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of cecum and/or colon and/or rectum after neoadjuvant antineoplastic therapy
1
Presence of regression of primary malignant neoplasm of central nervous system after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of esophagus after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of liver after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of lung after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of pancreas after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of pleural membrane after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of prostate after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of soft tissue after neoadjuvant antineoplastic therapy
1
Presence of regression of primary malignant neoplasm of stomach after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of thymus after neoadjuvant antineoplastic therapy
Presence of regression of primary malignant neoplasm of uterine adnexa after neoadjuvant antineoplastic therapy
2
